• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 995
Device Problem Insufficient Information (3190)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Blood Loss (2597)
Event Date 08/29/2012
Event Type  Injury  
Manufacturer Narrative
Citation: finch, jonathan.Failing stentless aortic valves: redo aortic root replacement or valve in a valve? european journal of cardio-thoracic surgery.(2012).43: 495¿504 doi 10.1093/ejcts/ezs335 earliest date of e-publish/publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it cannot be determined whether this event has been previously reported.(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature review regarding redo aortic root replacement versus valve-in-valve treatment for failed stentless aortic valves.All data were collected from a single center between 2000 and 2010.The study population included a total of 101 patients.Sixty-five patients (predominantly male; average age 61.5 ± 14.2 years) underwent a valve-in-valve replacement (group a).Forty-five patients (predominantly male; average age 61.9 ± 12.1 years), underwent a redo root replacement (group b).Group b contained one patient who had been implanted with a medtronic freestyle aortic root (serial numbers not provided).During the redo procedure medtronic mosaic, mosaic ultra and freestyle valve were implanted.Among all patients implanted with a freestyle adverse events included: electrocardiogram (ecg) changes treated with a permanent pacemaker, cerebral vascular accident (cva), bleeding treated with re-sternotomy, aortic regurgitation and stenosis.Based on the available information, these events may have been attributed to a medtronic product, however a direct correlation could not be made between the observed adverse events and medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE AORTIC ROOT BIOPROSTHESIS
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6744194
MDR Text Key81052192
Report Number2025587-2017-01244
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 07/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number995
Device Catalogue Number995
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/05/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-